CNO Financial Group, Inc. (CNO) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CNO, 39.74$ (piyasa değeri 4B) fiyatla Financial Services işi olan CNO Financial Group, Inc.'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 55/100 puan alıyor.
Son analiz: 9 Şub 2026CNO Financial Group, Inc. (CNO) Finansal Hizmetler Profili
CNO Financial Group delivers tailored insurance solutions for the senior and middle-income markets, leveraging a multi-brand strategy and diverse distribution network to capture a significant share of the growing retirement and pre-retirement demographic, offering investors stable dividend income and moderate growth potential.
Yatırım Tezi
CNO Financial Group presents a notable research candidate due to its strategic focus on the underserved senior and middle-income markets, which are experiencing significant growth. With a P/E ratio of 14.94 and a dividend yield of 1.50%, CNO offers a blend of value and income. Key value drivers include the company's multi-brand strategy, diverse distribution network, and a comprehensive product portfolio tailored to the needs of its target demographic. Upcoming catalysts include the continued expansion of its Medicare Advantage offerings and strategic acquisitions to enhance its market presence. CNO's ability to maintain a healthy profit margin of 6.6% and capitalize on the aging population positions it for sustained growth and attractive returns for investors.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $4.26 billion, reflecting a substantial and established presence in the insurance market.
- P/E ratio of 14.94, indicating a potentially undervalued stock relative to its earnings.
- Profit margin of 6.6%, demonstrating the company's ability to generate profits from its operations.
- Gross margin of 40.3%, showcasing efficient cost management in its insurance product offerings.
- Dividend yield of 1.50%, providing a steady income stream for investors.
Rakipler & Benzerleri
Güçlü Yönler
- Strong brand recognition in target markets.
- Diverse distribution network.
- Focus on the growing senior and middle-income segments.
- Comprehensive product portfolio.
Zayıflıklar
- Exposure to interest rate fluctuations.
- Regulatory compliance challenges.
- Competition from larger, more diversified insurance companies.
- Potential for increased claims costs.
Katalizörler
- Upcoming: Expansion of Medicare Advantage offerings to new geographic markets.
- Ongoing: Strategic acquisitions to enhance market presence and product portfolio.
- Ongoing: Digital transformation initiatives to improve customer experience and operational efficiency.
- Ongoing: Product innovation to meet evolving customer needs and emerging risks.
Riskler
- Potential: Changes in healthcare regulations impacting Medicare Advantage profitability.
- Potential: Increased competition from larger, more diversified insurance companies.
- Potential: Economic downturn impacting consumer spending on insurance products.
- Potential: Adverse investment performance affecting profitability.
- Ongoing: Interest rate fluctuations impacting investment income and profitability.
Büyüme Fırsatları
- Expansion of Medicare Advantage Offerings: CNO can capitalize on the growing Medicare Advantage market by expanding its product offerings and geographic reach. The Medicare Advantage market is projected to continue growing as more seniors opt for managed care plans. CNO's established distribution network and brand recognition provide a competitive advantage in capturing a larger share of this market. Timeline: Ongoing.
- Strategic Acquisitions: CNO can pursue strategic acquisitions to expand its product portfolio, enter new markets, and enhance its distribution capabilities. Acquisitions can provide access to new technologies, customer segments, and distribution channels, accelerating CNO's growth trajectory. Identifying and integrating synergistic acquisitions will be critical to success. Timeline: Ongoing.
- Digital Transformation: Investing in digital technologies to enhance customer experience, streamline operations, and improve data analytics can drive growth and efficiency. Digital channels can expand CNO's reach, reduce costs, and improve customer engagement. Leveraging data analytics can enable CNO to better understand customer needs and tailor its product offerings. Timeline: Ongoing.
- Product Innovation: Developing new and innovative insurance and financial products tailored to the evolving needs of the senior and middle-income markets can drive growth and differentiation. This includes products that address emerging risks, such as long-term care and chronic illnesses. Continuous product innovation is essential to maintaining a competitive edge. Timeline: Ongoing.
- Worksite and Group Sales Expansion: Focusing on expanding worksite and group sales for businesses, associations, and other membership groups can provide access to a broader customer base. By interacting with customers at their place of employment, CNO can increase awareness of its products and services and drive sales. Building strong relationships with employers and associations is key to success. Timeline: Ongoing.
Fırsatlar
- Expansion of Medicare Advantage offerings.
- Strategic acquisitions to enhance market presence.
- Digital transformation to improve customer experience and efficiency.
- Product innovation to meet evolving customer needs.
Tehditler
- Changes in healthcare regulations.
- Increased competition from new entrants.
- Economic downturn impacting consumer spending.
- Adverse investment performance.
Rekabet Avantajları
- Established brand recognition through Bankers Life, Washington National, and Colonial Penn.
- Extensive distribution network comprising agents, independent producers, and direct marketing channels.
- Focus on the underserved senior and middle-income markets.
- Proprietary underwriting and risk management expertise.
CNO Hakkında
CNO Financial Group, Inc. was established in 1979 and has evolved into a prominent provider of insurance and financial services, primarily targeting the senior and middle-income segments of the United States population. Headquartered in Carmel, Indiana, CNO operates through its subsidiaries, developing, marketing, and administering a diverse portfolio of health insurance, annuity, individual life insurance, and other insurance products. The company's core offerings include Medicare supplement, supplemental health, and long-term care insurance policies, alongside life insurance and annuities, including fixed index and fixed interest annuities. CNO distinguishes itself through a multi-brand strategy, marketing its products under the well-recognized names of Bankers Life, Washington National, and Colonial Penn. These brands cater to distinct customer needs and preferences, enhancing CNO's market reach and penetration. The company utilizes a multi-channel distribution approach, selling its products through agents, independent producers, and direct marketing efforts, including phone, online, and mail channels, as well as face-to-face interactions. This comprehensive distribution network enables CNO to effectively engage with its target demographic and provide personalized service. CNO's focus on the senior and middle-income markets positions it to capitalize on the increasing demand for retirement and healthcare-related financial products, driven by the aging population and rising healthcare costs. The company's commitment to product innovation and customer service supports its long-term growth and profitability.
Ne Yaparlar
- Develop and market health insurance products for seniors and middle-income individuals.
- Offer Medicare supplement and Medicare Advantage plans.
- Provide supplemental health insurance, including specified disease, accident, and hospital indemnity products.
- Administer long-term care insurance policies.
- Offer individual life insurance products, including whole life, term life, and universal life.
- Provide annuity products, including fixed index and fixed interest annuities.
- Distribute products through agents, independent producers, and direct marketing channels.
İş Modeli
- CNO generates revenue from premiums collected on insurance policies.
- Investment income from the company's investment portfolio contributes to overall profitability.
- Fees and commissions from the sale of annuity products provide additional revenue streams.
- Effective risk management and underwriting practices are crucial for maintaining profitability.
Sektör Bağlamı
CNO Financial Group operates within the life insurance industry, which is currently experiencing tailwinds from an aging population and increasing demand for retirement and healthcare-related financial products. The market is competitive, with key players like American Financial Group (AFG), Athene (ATH), and Brookfield Reinsurance (BHF) vying for market share. CNO differentiates itself through its focus on the senior and middle-income segments and its multi-brand distribution strategy. The industry is also influenced by regulatory changes and interest rate fluctuations, which can impact profitability and investment returns.
Kilit Müşteriler
- Seniors seeking health insurance and retirement income solutions.
- Middle-income individuals looking for affordable life insurance and financial protection.
- Businesses and associations offering employee benefits packages.
- Retirees and older self-employed individuals in the middle-income market.
Finansallar
Grafik & Bilgi
CNO Financial Group, Inc. (CNO) hisse senedi fiyatı: $39.74 (-0.17, -0.43%)
Son Haberler
-
3 Insurance Stocks Walking a Fine Line
StockStory · 19 Mar 2026
-
Prudential Financial Lags Industry, Trades at a Discount: Time to Hold?
Zacks · 17 Şub 2026
-
Earnings Scheduled For February 5, 2026
benzinga · 5 Şub 2026
-
Earnings Scheduled For November 3, 2025
benzinga · 3 Kas 2025
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
CNO için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
Konsensüs hedefi: $46.50
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, CNO'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Rakipler & Benzerleri
CNO Hakkında Sıkça Sorulan Sorular
CNO için değerlendirilmesi gereken temel faktörler nelerdir?
CNO Financial Group, Inc. (CNO) şu anda yapay zeka skoru 55/100, orta puanı gösteriyor. Hisse 17.5x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) altında, potansiyel değer sinyali. Analist hedefi $46.50 ($39.74'dan +17%). Temel güçlü yan: Strong brand recognition in target markets.. İzlenmesi gereken birincil risk: Potential: Changes in healthcare regulations impacting Medicare Advantage profitability.. Bu bir finansal tavsiye değildir.
CNO MoonshotScore'u nedir?
CNO şu anda MoonshotScore'da 55/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
CNO verileri ne sıklıkla güncellenir?
CNO fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler CNO hakkında ne diyor?
Analistler, CNO için $46.50 konsensüs fiyat hedefi belirledi, bu mevcut fiyattan ($39.74) yukarı yönlü %17 potansiyeli temsil ediyor. Kapsam, al, tut ve sat derecelendirmelerini, kazanç tahminlerini ve son yükseltmeleri veya düşürmeleri içerir. Tüm ayrıntılar için bu sayfadaki Analist Konsensüsü bölümüne bakın.
CNO'a yatırım yapmanın riskleri nelerdir?
CNO için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Changes in healthcare regulations impacting Medicare Advantage profitability.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
CNO'ın P/E oranı nedir?
CNO Financial Group, Inc. (CNO)'nın son P/E oranı 17.5, ki bu da piyasa ortalamasının altında, bu da göreli değeri gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.
CNO aşırı değerli mi, yoksa düşük değerli mi?
CNO Financial Group, Inc. (CNO)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 17.5. Analist hedefi $46.50 (mevcut fiyattan +17%), analistlerin yukarı yönlü potansiyel gördüğünü gösteriyor. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
CNO'ın temettü verimi nedir?
CNO Financial Group, Inc. (CNO) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Financial data may be delayed.
- AI analysis is based on available information and may not be comprehensive.